Chronic treatment with amyloid β1-42 inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling

Brain Research

Volumn 1062, Issue 1-2, 2005, Pages 101-110

  Nováková, Jana ^a   Mikasová, Lenka ^a   Machová, Eva ^a   Lisá, Věra ^a   Doležal, Vladimír ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

amyloid; Choline transporter 1; Choline transporter like protein; Hemicholinium 3 binding; High affinity choline transport; Protein kinase C

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CARNITINE; CASPASE 3; CASPASE 8; CHOLINE; CHOLINE TRANSPORTER LIKE PROTEIN; DEOXYGLUCOSE; HEMICHOLINIUM 3; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; PROTEIN KINASE C; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CELL DIFFERENTIATION; CELL GROWTH; CHOLINE UPTAKE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEXOSE TRANSPORT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHOLINERGIC AGENTS; HEMICHOLINIUM 3; MEMBRANE TRANSPORT PROTEINS; MICE; NEURONS; PEPTIDE FRAGMENTS; PROTEIN KINASE C; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 27744573850     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.09.021     Document Type: Article

References (50)

1. S. Apparsundaram, S.M. Ferguson, A.L. George Jr., and R.D. Blakely Molecular cloning of a human, hemicholinium-3-sensitive choline transporter Biochem. Biophys. Res. Commun. 276 2000 862 867
2. D.S. Auld, T.J. Kornecook, S. Bastianetto, and R. Quirion Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies Prog. Neurobiol. 68 2002 209 245
3. R.T. Bartus, R.L. Dean, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
4. E.M. Blanc, M. Toborek, R.J. Mark, B. Hennig, and M.P. Mattson Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells J. Neurochem. 68 1997 1870 1881
5. J.K. Blusztajn Choline, a vital amine Science 281 1998 794 795
6. J.A. Carson, and A.J. Turner Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J. Neurochem. 81 2002 1 8
7. X. Castell, M.F. Diebler, M. Tomasi, C. Bigari, S. De Gois, S. Berrard, J. Mallet, M. Israel, and V. Doležal More than one way to toy with ChAT and VAChT J. Physiol. (Paris) 96 2002 61 72
8. J.M. Cermak, T. Holler, D.A. Jackson, and J.K. Blusztajn Prenatal availability of choline modifies development of the hippocampal cholinergic system FASEB J. 12 1998 349 357
9. Y.H. Che, T. Yamashita, H. Higuchi, and M. Tohyama Changes in mRNA for choline transporter-like protein following facial nerve transection Brain Res. Mol. Brain Res. 101 2002 122 125
10. M.F. Diebler, M. Tomasi, F.M. Meunier, M. Israël, and V. Doležal Influence of retinoic acid and of cyclic AMP on the expression of choline acetyltransferase and of vesicular acetylcholine transporter in NG108-15 cells J. Physiol. (Paris) 92 1998 379 384
11. V. Doležal, and J. Kašparová Beta-amyloid and cholinergic neurons Neurochem. Res. 28 2003 499 506
12. V. Doležal, X. Castell, M. Tomasi, and M.F. Diebler Stimuli that induce a cholinergic neuronal phenotype of NG108-15 cells upregulate ChAT and VAChT mRNAs but fail to increase VAChT protein Brain Res. Bull. 54 2001 363 373
13. V. Doležal, V. Lisá, M.F. Diebler, J. Kaš parová, and S. Tuček Differentiation of NG108-15 cells induced by the combined presence of dbcAMP and dexamethasone brings about the expression of N and P/Q types of calcium channels and the inhibitory influence of muscarinic receptors on calcium influx Brain Res. 910 2001 134 141
14. O.M. El-Agnaf, D.S. Mahil, B.P. Patel, and B.M. Austen Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease Biochem. Biophys. Res. Commun. 273 2000 1003 1007
15. J.D. Erickson, H. Varoqui, M.K. Schafer, W. Modi, M.F. Diebler, E. Weihe, J. Rand, L.E. Eiden, T.I. Bonner, and T.B. Usdin Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus J. Biol. Chem. 269 1994 21929 21932
16. R. Etcheberrigaray, J.L. Payne, and D.L. Alkon Soluble beta-amyloid induces Alzheimer's disease features in human fibroblasts and in neuronal tissues Life Sci. 59 1996 491 498
17. S.M. Ferguson, M. Bazalakova, V. Savchenko, J.C. Tapia, J. Wright, and R.D. Blakely Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 8762 8767
18. P.T. Francis, A.M. Palmer, M. Snape, and G.K. Wilcock The cholinergic hypothesis of Alzheimer's disease: a review of progress J. Neurol., Neurosurg. Psychiatry 66 1999 137 147
19. Y. Gong, L. Chang, K.L. Viola, P.N. Lacor, M.P. Lambert, C.E. Finch, G.A. Krafft, and W.L. Klein Alzheimer's disease-affected brain: presence of oligomeric A{beta} ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc. Natl. Acad. Sci. U. S. A. 2003 10417 10422
20. G.K. Gouras Current theories for the molecular and cellular pathogenesis of Alzheimer's disease Expert Rev. Mol. Med. 2001 2001 1 11
21. S.X. Guo-Ross, S. Clark, D.A. Montoya, K.H. Jones, J. Obernier, A.K. Shetty, A.M. White, J.K. Blusztajn, W.A. Wilson, and H.S. Swartzwelder Prenatal choline supplementation protects against postnatal neurotoxicity J. Neurosci. 22 2002 RC195
22. S.X. Guo-Ross, K.H. Jones, A.K. Shetty, W.A. Wilson, and H.S. Swartzwelder Prenatal dietary choline availability alters postnatal neurotoxic vulnerability in the adult rat Neurosci. Lett. 341 2003 161 163
23. B. Hamprecht Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture Int. Rev. Cytol. 49 1977 99 170
24. B. Hamprecht, T. Glaser, G. Reiser, E. Bayer, and F. Propst Culture and characteristics of hormone-responsive neuroblastoma X glioma hybrid cells Methods Enzymol. 109 1985 316 341
25. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
26. T. Holler, B. Berse, J.M. Cermak, M.F. Diebler, and J.K. Blusztajn Differences in the developmental expression of the vesicular acetylcholine transporter and choline acetyltransferase in the rat brain Neurosci. Lett. 212 1996 107 110
27. M. Ishiguro, I. Ohsawa, C. Takamura, T. Morimoto, and S. Kohsaka Secreted form of beta-amyloid precursor protein activates protein kinase C and phospholipase Cgamma1 in cultured embryonic rat neocortical cells Brain Res. Mol. Brain Res. 53 1998 24 32
28. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325 1987 733 736
29. S. Kar, D. Seto, P. Gaudreau, and R. Quirion Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices J. Neurosci. 16 1996 1034 1040
30. S. Kar, A.M. Issa, D. Seto, D.S. Auld, B. Collier, and R. Quirion Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices J. Neurochem. 70 1998 2179 2187
31. J. Kašparová, V. Lisá, S. Tuček, and V. Doležal Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta(1-42)) abolishes calcium influx via N-type calcium channels Neurochem. Res. 26 2001 1079 1084
32. F. Kuperstein, N. Reiss, N. Koudinova, and E. Yavin Biphasic modulation of protein kinase C and enhanced cell toxicity by amyloid beta peptide and anoxia in neuronal cultures J. Neurochem. 76 2001 758 767
33. Y. Luo, D.B. Hawver, K. Iwasaki, T. Sunderland, G.S. Roth, and B. Wolozin Physiological levels of beta-amyloid peptide stimulate protein kinase C in PC12 cells Brain Res. 769 1997 287 295
34. W.H. Meck, and C.L. Williams Characterization of the facilitative effects of perinatal choline supplementation on timing and temporal memory NeuroReport 8 1997 2831 2835
35. W.H. Meck, and C.L. Williams Simultaneous temporal processing is sensitive to prenatal choline availability in mature and aged rats NeuroReport 8 1997 3045 3051
36. T.J. Mellott, C.L. Williams, W.H. Meck, and J.K. Blusztajn Prenatal choline supplementation advances hippocampal development and enhances MAPK and CREB activation FASEB J. 18 2004 545 547
37. F.M. Meunier, and S. O'Regan Expression of CTL1 in myelinating structures of Torpedo marmorata NeuroReport 13 2002 1617 1620
38. S. O'Regan, and F.M. Meunier Selection and characterization of the choline transport mutation suppressor from Torpedo electric lobe, CTL1 Neurochem. Res. 28 2003 551 555
39. S. O'Regan, E. Traiffort, M. Ruat, N. Cha, D. Compaore, and F.M. Meunier An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins Proc. Natl. Acad. Sci. U. S. A. 97 2000 1835 1840
40. T. Okuda, and T. Haga Functional characterization of the human high-affinity choline transporter FEBS Lett. 484 2000 92 97
41. T. Okuda, T. Haga, Y. Kanai, H. Endou, T. Ishihara, and I. Katsura Identification and characterization of the high-affinity choline transporter Nat. Neurosci. 3 2000 120 125
42. S. Oshima, K. Yamada, T. Shirakawa, and M. Watanabe Changes of high-affinity choline transporter CHT1 mRNA expression during degeneration and regeneration of hypoglossal nerves in mice Neurosci. Lett. 365 2004 97 101
43. G.K. Pyapali, D.A. Turner, C.L. Williams, W.H. Meck, and H.S. Swartzwelder Prenatal dietary choline supplementation decreases the threshold for induction of long-term potentiation in young adult rats J. Neurophysiol. 79 1998 1790 1796
44. S. Rossner, G. Mehlhorn, R. Schliebs, and V. Bigl Increased neuronal and glial expression of protein kinase C isoforms in neocortex of transgenic Tg2576 mice with amyloid pathology Eur. J. Neurosci. 13 2001 269 278
45. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
46. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
47. S. Tanimukai, H. Hasegawa, M. Nakai, K. Yagi, M. Hirai, N. Saito, T. Taniguchi, A. Terashima, M. Yasuda, T. Kawamata, and C. Tanaka Nanomolar amyloid beta protein activates a specific PKC isoform mediating phosphorylation of MARCKS in Neuro2A cells NeuroReport 13 2002 549 553
48. E. Traiffort, M. Ruat, S. O'Regan, and F.M. Meunier Molecular characterization of the family of choline transporter-like proteins and their splice variants J. Neurochem. 92 2005 1116 1125
49. M. Vestling, A. Cedazo-Minguez, A. Adem, B. Wiehager, M. Racchi, L. Lannfelt, and R.F. Cowburn Protein kinase C and amyloid precursor protein processing in skin fibroblasts from sporadic and familial Alzheimer's disease cases Biochim. Biophys. Acta 1453 1999 341 350
50. P. Zhong, Z. Gu, X. Wang, H. Jiang, J. Feng, and Z. Yan Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer's disease J. Biol. Chem. 2003 26888 26896